UPS Healthcare Logistics picks up an asset in Poland
Poltraf acquisition adds to a network of 14 facilities serving Eastern and Western Europe
Continuing a European-growth strategy that the company has been engaged in for the past three years in healthcare logistics, UPS has announced the acquisition of Poltraf Sp z, from a Polish investment fund, Ortie. Price is undisclosed. Poltraf, based in Brionie, near Warsaw, has three facilities with “advanced warehouse management systems,” as UPS’ news release puts it, along with a fleet of 170 temperature-controlled vehicles for transporting refrigerated (2-8°C) and controlled room-temperature (15-25°C) products. It also has a network of 10 field stocking locations in Poland.
The announcement follows UPS’s acquisitions of a UK-based express-delivery service, Polar Speed, in February 2014; Hungary-based pharmaceutical logistics company, Cemelog, in 2013; and Italy-based, Pieffe, in 2011. “Poltraf complements our mainland Europe expansion plan and we are now able to provide healthcare companies access to a single source for logistics solutions across the continent,” said Cindy Miller, president, UPS Europe, in a statement.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
